07 August 2017 : Clinical Research
Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
DOI: 10.12659/MSM.903054
Med Sci Monit 2017; 23:3824-3830
HTML version available soon